share_log

UnitedHealth | 10-Q: Q3 2024 Earnings Report

UnitedHealth | 10-Q: Q3 2024 Earnings Report

联合健康 | 10-Q:2024财年三季报
美股SEC公告 ·  11/05 05:25

Moomoo AI 已提取核心信息

UnitedHealth Group Incorporated reported a 9% increase in consolidated revenues to $100.82 billion for the third quarter of 2024, compared to $92.36 billion in the same period last year. The revenue growth was primarily driven by the company's Optum Rx and Optum Health segments, as well as growth across UnitedHealthcare's domestic offerings. Earnings from operations rose slightly to $8.7 billion from $8.5 billion year-over-year. However, net earnings attributable to UnitedHealth Group common shareholders saw a 4% increase to $6.055 billion, with diluted earnings per share at $6.51. The company served 2.0 million more people domestically, mainly due to growth in commercial offerings, despite the impact of Medicaid redeterminations. UnitedHealthcare's revenues increased by 7% to $74.85 billion, while Optum's revenues grew by 13% to $63.92 billion. The medical care...Show More
UnitedHealth Group Incorporated reported a 9% increase in consolidated revenues to $100.82 billion for the third quarter of 2024, compared to $92.36 billion in the same period last year. The revenue growth was primarily driven by the company's Optum Rx and Optum Health segments, as well as growth across UnitedHealthcare's domestic offerings. Earnings from operations rose slightly to $8.7 billion from $8.5 billion year-over-year. However, net earnings attributable to UnitedHealth Group common shareholders saw a 4% increase to $6.055 billion, with diluted earnings per share at $6.51. The company served 2.0 million more people domestically, mainly due to growth in commercial offerings, despite the impact of Medicaid redeterminations. UnitedHealthcare's revenues increased by 7% to $74.85 billion, while Optum's revenues grew by 13% to $63.92 billion. The medical care ratio (MCR) increased to 85.2% from 82.3%, reflecting higher medical costs. The company also faced challenges, including a cyberattack on Change Healthcare, which resulted in direct response costs and business disruption impacts totaling $1.7 billion for the nine months ended September 30, 2024. Looking ahead, UnitedHealth Group expects to continue incurring costs related to the cyberattack and is working to restore transaction volumes to pre-event levels. The company remains focused on balancing growth and profitability, managing medical costs, and adapting to regulatory changes.
联合健康集团报告称,2024年第三季度综合营业收入增长了9%,达到了1008.2亿美元,相比去年同期的923.6亿美元。营收增长主要得益于公司的Optum Rx和Optum Health部门以及UnitedHealthcare国内业务的增长。营运收益从去年的85亿美元略微上升至87亿美元。然而,归属联合健康集团普通股东的净收入增长了4%,达到了60.55亿美元,每股股份摊薄收益为6.51美元。该公司在国内为更多的200万人提供了服务,主要是由于商业产品的增长,尽管存在医疗补助再确定的影响。UnitedHealthcare的营收增长了7%,达到了748.5亿美元,而Optum的营收增长了13%,...展开全部
联合健康集团报告称,2024年第三季度综合营业收入增长了9%,达到了1008.2亿美元,相比去年同期的923.6亿美元。营收增长主要得益于公司的Optum Rx和Optum Health部门以及UnitedHealthcare国内业务的增长。营运收益从去年的85亿美元略微上升至87亿美元。然而,归属联合健康集团普通股东的净收入增长了4%,达到了60.55亿美元,每股股份摊薄收益为6.51美元。该公司在国内为更多的200万人提供了服务,主要是由于商业产品的增长,尽管存在医疗补助再确定的影响。UnitedHealthcare的营收增长了7%,达到了748.5亿美元,而Optum的营收增长了13%,达到了639.2亿美元。医疗保健比例(MCR)从82.3%上升至85.2%,反映出更高的医疗成本。此外,该公司还面临挑战,包括对Change Healthcare的网络攻击,导致截至2024年9月30日的九个月出现直接响应成本和业务中断影响合计17亿美元。展望未来,联合健康集团预计继续承担与网络攻击相关的成本,并努力恢复交易量至事件前水平。该公司继续专注于平衡增长和盈利能力,管理医疗成本,并适应监管变化。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息